Sugar vs. blood patch for air leak after lung surgery
Part of Cancer, Lungs & breathing clinical trials.
This study compares two treatments for a stubborn air leak that continues more than 5 days after lung surgery. One treatment uses a concentrated sugar solution, the other uses your own blood to patch the leak. The goal is to see which works better to stop the leak and help you heal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had surgery to remove part of a lung (segmentectomy, lobectomy, or bilobectomy) between November 2023 and December 2024.
- You have a persistent air leak that has lasted more than 5 days after your surgery.
- You are willing to have a procedure using either a sugar solution or your own blood to seal the leak.
- You do not have an active infection or sepsis, and you do not need urgent surgery to fix the leak.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether an “autologous blood patch” (using your own blood) can help stop an air leak after certain lung operations. It’s designed for adults who still have an air leak on the morning of the third day after surgery.
This trial tests a two-step procedure that uses small valves and a blood patch to close persistent air leaks in the lung. It could be an option for people who cannot have or don't want surgery.
This study tests whether injecting a sugar solution (dextrose) into the space around your lungs can help heal air leaks that persist after lung surgery. Air leaks can delay recovery, and this treatment may help seal them without additional surgery.
This trial is for people with a collapsed lung (pneumothorax) that has a persistent air leak. It tests whether talc or a blood patch can seal the leak and help the lung re-inflate.
This study looks at whether TissuePatch SF can prevent air leaks after lung surgery. You may be able to join if you are having planned lung surgery and fit the health requirements.
This trial tests a device called Thopaz for people who have a stubborn air leak in the lung (an air leak that hasn't healed after 5 days of chest tube drainage). The study is for those who are already scheduled for a bronchoscopy to address the leak, and aims to see if Thopaz can help stop the leak faster.
Hear when a new Prolonged Air Leak trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.